TransMedics Group, Inc. Paid-in-Kind Interest
TransMedics Group, Inc. (TMDX) reported Paid-in-Kind Interest of $352.00 thousand for the 9-month period ending 2019-09-28, per its 10-Q filed 2019-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2019-11-08
- TransMedics Group, Inc. paid-in-kind interest for the quarter ending 2019-09-28 was $121.00K.
- TransMedics Group, Inc. paid-in-kind interest for the quarter ending 2019-06-29 was $116.00K.
- TransMedics Group, Inc. paid-in-kind interest for the quarter ending 2019-03-30 was $115.00K, a 91.67% increase year-over-year.
- TransMedics Group, Inc. paid-in-kind interest for the quarter ending 2018-06-30 was -$12.00K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month |
|---|---|---|---|
| 2019-09-28 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $237.00K derived: sum of 2 quarters · filed 2019-11-08 | $352.00K 10-Q · filed 2019-11-08 |
| 2019-06-29 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $231.00K 10-Q · filed 2019-08-08 | |
| 2019-03-30 | $115.00K 10-Q · filed 2019-06-12 | ||
| 2018-09-29 | $116.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $48.00K 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $60.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |